Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hercules Capital, Inc. Common Stock (NY:HTGC)

16.27 +0.22 (+1.40%)
Streaming Delayed Price Updated: 3:36 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hercules Capital, Inc. Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
These Stocks Are On A Dividend Increase Bonanza ↗
Today I want to provide a list of BDCs that have announced dividend increases and/or supplemental dividends and which ones to look at for your portfolio. 
Via Talk Markets
News headline image
Hercules Capital: Dividend Insights ↗
 
Via Benzinga
News headline image
Hercules Capital Announces Upcoming Event for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
News headline image
Hercules Capital Reports Fourth Quarter and Full-Year 2022 Financial Results
From Hercules Capital, Inc.
Via Business Wire
News headline image
Earnings Scheduled For February 16, 2023 ↗
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
News headline image
Expert Ratings for Hercules Capital ↗
Analysts have provided the following ratings for Hercules Capital (NYSE:HTGC) within the last quarter: 
Via Benzinga
News headline image
IVERIC bio Shares Jump On Debt Financing To Fund Zimura Launch ↗
 
Via Benzinga
News headline image
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 per Share
From Hercules Capital, Inc.
Via Business Wire
News headline image
Hercules Capital Increases Its Quarterly Cash Distribution to $0.39 per Share for the Fourth Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
News headline image
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2022 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
News headline image
Daily Stock Analysis: Hercules Capital Inc. ↗
Hercules Capital Inc. is a small-cap asset management company operating in the financial services business sector. 
Via Talk Markets
News headline image
AmplifyBio Secures $50M in Debt Financing With Hercules Capital to Accelerate Business Plan
AmplifyBio announces $50M in debt financing to accelerate the expansion of its service offering, supporting the rapid, safe development of next-generation therapeutics 
Via Newswire.com
News headline image
Hercules Capital Announces Upcoming Event for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
News headline image
Hercules Capital Announces Upcoming Events for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
News headline image
Hercules Capital Reports Third Quarter 2022 Financial Results
From Hercules Capital, Inc.
Via Business Wire
News headline image
Phathom Pharmaceuticals Announces Placement of the Remaining $40 Million in Non-Dilutive Capital under its up to $300 Million Revenue Interest Financing Agreement
From Phathom Pharmaceuticals
Via GlobeNewswire
News headline image
As Small Caps Rally, These 3 Finance High-Yielders Could Have Further Upside ↗
In the past month with the Russell 2000 index up roughly 7%, as compared to the S&P 500 index up nearly 4.8%, it is evident that small cap stocks are leading the charge in this bear market rally. The... 
Via Benzinga
News headline image
4 Analysts Have This to Say About Hercules Capital ↗
Over the past 3 months, 4 analysts have published their opinion on Hercules Capital (NYSE:HTGC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Hercules Capital Announces Date for Release of Third Quarter 2022 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
News headline image
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Third Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
News headline image
Hercules Capital Increases Its Quarterly Cash Distribution to $0.36 per Share for the Third Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
News headline image
Replimune Gets 33% Price Target Bump Ahead Of Upcoming Readouts. Analyst Lists The Catalysts ↗
 
Via Benzinga
News headline image
The 2 Best Stocks For Even Higher Interest Rates ↗
Even if the future is messy and it’s hard to guess what will happen, there are investment strategies that will get you through the next couple of years and beyond. Here are two stocks worth a closer... 
Via Talk Markets
News headline image
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
From Hercules Capital, Inc.
Via Business Wire
News headline image
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report ↗
Clinical-stage psychedelics company ATAI Life Sciences N.V. (NASDAQ: ATAI) announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility... 
Via Benzinga
News headline image
The 2 Best Stocks For The 2022 Recession ↗
Let’s take a look at how this recession will affect the giant mega-cap companies that most investors follow, as well as some smaller companies operating in specific business niches. The difference will... 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022 ↗
  
Via Benzinga
News headline image
Hercules Capital Reports Second Quarter 2022 Financial Results
From Hercules Capital, Inc.
Via Business Wire
News headline image
Earnings Preview For Hercules Capital ↗
Hercules Capital (NYSE:HTGC) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that Hercules... 
Via Benzinga
News headline image
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.